National Quality Measures Clearinghouse | Cancer - fatigue/anemia: RAND Corporation.

RAND Corporation


Cancer - fatigue/anemia: percentage of known cancer patients who are newly diagnosed with cancer who had an assessment of the presence or absence of fatigue.

full-text:
National Quality Measures Clearinghouse | Cancer - fatigue/anemia: percentage of known cancer patients who are newly diagnosed with cancer who had an assessment of the presence or absence of fatigue.


Cancer - fatigue/anemia: percentage of patients found to have anemia with a hemoglobin less than 10 g/dl for whom the presence and severity of anemia-related symptoms (e.g., fatigue, dyspnea, and lightheadedness) were evaluated.

full-text:
National Quality Measures Clearinghouse | Cancer - fatigue/anemia: percentage of patients found to have anemia with a hemoglobin less than 10 g/dl for whom the presence and severity of anemia-related symptoms (e.g., fatigue, dyspnea, and lightheadedness) were evaluated.


Cancer - fatigue/anemia: percentage of patients found to have severe, symptomatic anemia (hemoglobin less than 8 g/dl) for whom transfusion with packed red cells was offered within 24 hours.

full-text:
National Quality Measures Clearinghouse | Cancer - fatigue/anemia: percentage of patients found to have severe, symptomatic anemia (hemoglobin less than 8 g/dl) for whom transfusion with packed red cells was offered within 24 hours.


Cancer - fatigue/anemia: percentage of patients seen for an initial visit or any visit while undergoing chemotherapy at a cancer-related outpatient site for whom there was an assessment of the presence or absence of fatigue.

full-text:
National Quality Measures Clearinghouse | Cancer - fatigue/anemia: percentage of patients seen for an initial visit or any visit while undergoing chemotherapy at a cancer-related outpatient site for whom there was an assessment of the presence or absence of fatigue.